GOLM1 and neoplasm: GOLM1 is expressed at low levels in normal cells but is significantly upregulated in various cancers (e.g., liver, lung, prostate), with its expression level closely linked to tumor aggressiveness and poor prognosis (Sui et al. 2021; Song et al. 2021; Yamoah et al. 2015).